Mutational signatures impact the evolution of anti-EGFR antibody resistance in colorectal cancer-Reference-Cited by-同舟云学术

Mutational signatures impact the evolution of anti-EGFR antibody resistance in colorectal cancer

Published:2021-05-20 Issue:7 Volume:5 Page:1024-1032
ISSN:2397-334X
Container-title:Nature Ecology & Evolution
language:en
Short-container-title:Nat Ecol Evol

Author:

Woolston Andrew^ORCID,Barber Louise J.,Griffiths Beatrice,Pich Oriol,Lopez-Bigas Nuria,Matthews Nik,Rao Sheela,Watkins David,Chau Ian,Starling Naureen,Cunningham David^ORCID,Gerlinger Marco^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Ecology,Ecology, Evolution, Behavior and Systematics

Link

http://www.nature.com/articles/s41559-021-01470-8.pdf

Reference44 articles.

1. Karapetis, C. S. et al. K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N. Engl. J. Med. 359, 1757–1765 (2008).

2. Van Cutsem, E. et al. Fluorouracil, leucovorin, and irinotecan plus cetuximab treatment and RAS mutations in colorectal cancer. J. Clin. Oncol. 33, 692–700 (2015).

3. Woolston, A. et al. Genomic and transcriptomic determinants of therapy resistance and immune landscape evolution during anti-EGFR treatment in colorectal cancer. Cancer Cell 36, 35–50.e9 (2019).

4. Misale, S. et al. Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer. Nature 486, 532–536 (2012).

5. Bettegowda, C. et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci. Transl. Med. 6, 224ra24 (2014).

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive molecular characterization of early stage grade 3 endometrioid endometrial adenocarcinoma;Gynecologic Oncology;2024-10

2. Mutational Signatures in Colorectal Cancer: Translational Insights, Clinical Applications, and Limitations;Cancers;2024-08-24

3. Decoding the Dynamics of Circulating Tumor DNA in Liquid Biopsies;Cancers;2024-07-01

4. Mutational signatures of colorectal cancers according to distinct computational workflows;Briefings in Bioinformatics;2024-05-23

5. Bispecific antibody drug conjugates: Making 1+1>2;Acta Pharmaceutica Sinica B;2024-05